Altermed ApS: Financial statements 2024
CVR: 42504831
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Altermed ApS (CVR 42504831) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,603,770 and a net result of DKK 377,094 compared with DKK 784,777 the year before. That is an increase of 26.2% compared with the year before. Equity in the 2024 report amounted to DKK 4,826,941. The solvency ratio was 76.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,603,770
- Profit/Loss
- DKK 377,094
- Equity
- DKK 4,826,941
- Total Assets
- DKK 6,283,786
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.6 mio. | 377 t. | 4.8 mio. | 2 |
| 2023 | - | 2.1 mio. | 785 t. | 4.4 mio. | 2 |
| 2022 | - | 1.9 mio. | 683 t. | 3.7 mio. | 2 |
| 2021 | - | 2.9 mio. | 1.5 mio. | 3 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Altermed ApS has published its annual report for 2023. Gross profit came to DKK 2,063,221, and the net result was DKK 784,777.
About Altermed ApS
Altermed ApS is a Danish company of the type Anpartsselskab based in Viborg, founded in 2021. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The management consists of Jesper Ahrendt Boel. The company is owned by Jesper Ahrendt Boel. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 2,401,366 and a net result of DKK 174,635 compared with DKK 377,094 the year before. Equity in the 2025 report amounted to DKK 4,645,911.